4.5 Article

Identification of liver-derived bone morphogenetic protein (BMP)-9 as a potential new candidate for treatment of colorectal cancer

Journal

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 26, Issue 2, Pages 343-353

Publisher

WILEY
DOI: 10.1111/jcmm.17084

Keywords

bone morphogenetic protein-9; colorectal cancer; ID1; noggin

Funding

  1. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [393225014, 394046768-SFB1366]
  2. China Scholarship Council (CSC)
  3. Integrated Hospital of traditional Chinese Medicine, Southern Medical University

Ask authors/readers for more resources

The study revealed that BMP-9 can modulate the ratio between ID1 and noggin in colorectal cancer patients, significantly impacting patient survival rates. Experimental results showed that stimulation of organoids with BMP-9 promoted the expression of tumor suppressive genes, while noggin stimulation had the opposite effect.
Colorectal cancer (CRC) is a high-incidence malignancy worldwide which still needs better therapy options. Therefore, the aim of the present study was to investigate the responses of normal or malignant human intestinal epithelium to bone morphogenetic protein (BMP)-9 and to find out whether the application of BMP-9 to patients with CRC or the enhancement of its synthesis in the liver could be useful strategies for new therapy approaches. In silico analyses of CRC patient cohorts (TCGA database) revealed that high expression of the BMP-target gene ID1, especially in combination with low expression of the BMP-inhibitor noggin, is significantly associated with better patient survival. Organoid lines were generated from human biopsies of colon cancer (T-Orgs) and corresponding non-malignant areas (N-Orgs) of three patients. The N-Orgs represented tumours belonging to three different consensus molecular subtypes (CMS) of CRC. Overall, BMP-9 stimulation of organoids promoted an enrichment of tumour-suppressive gene expression signatures, whereas the stimulation with noggin had the opposite effects. Furthermore, treatment of organoids with BMP-9 induced ID1 expression (independently of high noggin levels), while treatment with noggin reduced ID1. In summary, our data identify the ratio between ID1 and noggin as a new prognostic value for CRC patient outcome. We further show that by inducing ID1, BMP-9 enhances this ratio, even in the presence of noggin. Thus, BMP-9 is identified as a novel target for the development of improved anti-cancer therapies of patients with CRC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available